Fig. 6a–c show the differential expression levels of integrin β2 subunit, talin-1, and kindlin-3, which were substantially upregulated in both innate immune cells and lymphocytes in MSC-treated COVID-19 patients compared with those in control samples. The gene discussed is TLN1; the disease is COVID-19.